These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 27870469)

  • 1. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
    Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
    Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
    PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis.
    Wang Z; Chen W; Zhang Y; Xu L; Wang Q
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs used as novel biomarkers for detecting cancer metastasis.
    Han C; Yu H; Zhang L; Li X; Feng Y; Xin H
    Tumour Biol; 2015 Mar; 36(3):1755-62. PubMed ID: 25366141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
    Zhang M; Zhao LJ; Liang WQ; Mao ZP
    Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
    Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
    Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis.
    Ma L; Wen Y; Li Z; Wu N; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():929924. PubMed ID: 35898469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus: a meta-analysis.
    Dai ZW; Wang H; Xu WJ; Wang ZH; Xu SQ; Wang B; Ye DQ
    Clin Rheumatol; 2018 Nov; 37(11):2999-3007. PubMed ID: 29980876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.
    Xiang Y; Zhang L; Xiang P; Zhang J
    Front Oncol; 2021; 11():698197. PubMed ID: 34307166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
    Wang C; Zhao K; Rong Q
    Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.